Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201108378 Principal Investigator: Pusic, Iskra
Title: Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
Phase: I Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The goal of this study is to determine the best dose of decitabine given after a transplant as maintenance therapy.

We will also evaluate how effective decitabine is in getting rid of remaining disease and providing disease control, by allowing the graft (donor T-cells) to attack and control the growth of remaining cancer cells.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)